Cargando…
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777025/ https://www.ncbi.nlm.nih.gov/pubmed/31581941 http://dx.doi.org/10.1186/s12936-019-2955-z |